Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TECX
3076
Tectonic Therapeutic
TECX
$606M
| $2.33M | ﹤0.01% |
76,879
+45,846
| +148% | +$838K |
|
3077
X4 Pharmaceuticals
XFOR
$460M
| $2.31M | ﹤0.01% |
114,917
-2,268
| -2% | -$47.3K |
|
3078
BRC Group Holdings
RILY
$289M
| $2.3M | ﹤0.01% |
437,126
-2,480
| -0.6% | -$27.5K |
|
|
ORGN
3079
DELISTED
Origin Materials
ORGN
| $2.29M | ﹤0.01% |
49,551
+2,925
| +6% | +$106K |
|
3080
Commercial Vehicle Group
CVGI
$147M
| $2.29M | ﹤0.01% |
704,325
+16,145
| +2% | +$65.8K |
|
3081
Delcath Systems
DCTH
$524M
| $2.28M | ﹤0.01% |
251,895
+7,298
| +3% | +$63.4K |
|
3082
Veru
VERU
$37.4M
| $2.26M | ﹤0.01% |
294,014
+13,172
| +5% | +$114K |
|
3083
ZIM Integrated Shipping Services
ZIM
$3.24B
| $2.26M | ﹤0.01% |
88,086
+2,873
| +3% | +$55.9K |
|
3084
Weibo
WB
$1.95B
| $2.25M | ﹤0.01% |
223,447
+98,017
| +78% | +$771K |
|
3085
Rimini Street
RMNI
$471M
| $2.24M | ﹤0.01% |
1,213,103
-14,263
| -1% | -$31.5K |
|
|
GRSD
3086
Grandstand Limited Ordinary Shares
GRSD
$67M
| $2.24M | ﹤0.01% |
223,714
+66
| +0% | +$626 |
|
3087
Ericsson
ERIC
$33.3B
| $2.23M | ﹤0.01% |
294,514
-570
| -0.2% | -$3.99K |
|
3088
Neuropace
NPCE
$506M
| $2.21M | ﹤0.01% |
317,192
+25,330
| +9% | +$185K |
|
|
HIVE
3089
HIVE Digital Technologies
HIVE
$777M
| $2.2M | ﹤0.01% |
703,605
-6,280
| -0.9% | -$20.5K |
|
3090
Empire Petroleum
EP
$111M
| $2.19M | ﹤0.01% |
417,692
+25,335
| +6% | +$130K |
|
3091
Cartesian Therapeutics
RNAC
$268M
| $2.19M | ﹤0.01% |
135,700
+2,737
| +2% | +$42.8K |
|
3092
EVI Industries
EVI
$180M
| $2.18M | ﹤0.01% |
112,988
-5,530
| -5% | -$99.2K |
|
3093
Silicon Motion
SIMO
$8.68B
| $2.18M | ﹤0.01% |
35,948
+253
| +0.7% | +$16.7K |
|
3094
Gossamer Bio
GOSS
$87M
| $2.18M | ﹤0.01% |
2,212,377
-71,241
| -3% | -$68.5K |
|
3095
Energy Vault
NRGV
$633M
| $2.18M | ﹤0.01% |
2,273,042
+177,214
| +8% | +$178K |
|
|
EVBN
3096
DELISTED
Evans Bancorp Inc
EVBN
| $2.17M | ﹤0.01% |
55,786
+3,583
| +7% | +$123K |
|
3097
Kyverna Therapeutics
KYTX
$484M
| $2.17M | ﹤0.01% |
443,312
+70,714
| +19% | +$545K |
|
3098
dLocal
DLO
$4.24B
| $2.16M | ﹤0.01% |
270,530
-23,818
| -8% | -$193K |
|
3099
Mammoth Energy Services
TUSK
$163M
| $2.16M | ﹤0.01% |
528,850
+9,852
| +2% | +$36.1K |
|
|
VXRT
3100
DELISTED
Vaxart
VXRT
| $2.16M | ﹤0.01% |
2,543,228
+346,725
| +16% | +$265K |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.